A panel of scientists at the forefront of using biotechnology to advance cannabis research and development discuss how tech is a driving force on the future of the cannabis industry. Specifically, the use of gene editing and it's different from genetic modification; reimagining cannabis cultivation; creating cannabis plants that overexpress trichomes and produce more rare cannabinoids; what this means for reducing the environmental impact of cultivation; how cellular pharmacology is yielding the secrets of rare cannabinoids and harnessing the entourage effect; how chromatography and other technologies are being used to extract rare cannabinoids; how research data can be visualized and shared; and what all these developments mean for the future of medical and adult-use marijuana markets.
- How the technique of editing genes is different from genetic modification
- How scientists are working to get more cannabinoids from fewer plants
- What are the latest developments in cannabis biotechnology that will change the future of the market?
- Jon Cooper, CEO, ebbu
Jon Cooper, CEO, ebbu
SXSW reserves the right to restrict access to or availability of comments related to PanelPicker proposals that it considers objectionable.